Forte Biosciences (FBRX) Misses Q2 EPS by 96c

Forte Biosciences (NASDAQ: FBRX) reported Q2 EPS of ($0.96).

For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.

You May Also Be Interested In

• Trump: Walmart will be lowering prices
• Goldman Sachs Downgrades Ferguson Plc. (FERG) to Neutral, 'We now see better opportunities elsewhere in our coverage'
• Cloudastructure restructures preferred stock, issues $1.3M promissory note